Three cases of primary thrombocythemia with cerebral thrombosis are reported.
Case 1 : A white-collar worker aged 53 was admitted to Shinshu University Hospital on October 4, 1978, because of cerebral thrombosis. He had a hitory of good health until 1975, when he began to have attacks of epigastralgia. He was not seen at hospital until May, 1976, when he was found to have hepatosplenomegaly. A blood test proved almost normal. A diagnosis of portal hypertension was considered most likely, and a splenectomy was carried out in July, 1976. Subsequently, successive blood tests always revealed thrombocythemia (range 1, 588, 000 to 2, 960, 000/mm
3.), and he experienced recurrent transient ischemic attacks with dysarthria and numbness of the right hand. Two years later he developed cerebral thrombosis.
Case 2 : A farmer aged 55 was admitted to Shinshu University Hospital on July 10, 1976, because of cerebral thrombosis. He was in good health until 1975, when he began to have transient ischemic attacks with dysarthria and gait disturbance. Several months later he developed cerebral thrombosis with dysarthria, ataxia, right hemiparesis, and periodic disturbance of consciousness.
Case 3 : A seventy-six-year-old woman was admitted to Shinshu University Hospital on July 18, 1979, because of right hemiballismus. Prior to admission she experienced transient ischemic attacks of unconsciousness and vertigo on January 17, 1979. A month later she developed cerebral thrombosis and two months later right hemiballismus appeared.
Each patient had a prolonged history characterized by transient ischemic attacks and developed cerebral thrombosis thereafter. All three cases were found to have thrombocythemia (more than one million/mm
3), and an increase of megakaryocytes in the bone marrow. There was no leukemic infiltration in bone marrow and the Philadelphia chromosome was absent in all patients. Each patient sufficed the diagnostic criteria of primary thrombocythemia. Their platlets showed decreased aggregation by ADP, epinephrine, and collagen, when they were diluted to 300, 000/mm
3. Clinical symptoms, platelet function, and therapy of primary thrombocythemia are discussed in each case.
View full abstract